硝西泮

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • 结构与计算化学
  • 上游产品
  • 下游产品
  • 表征图谱

硝西泮 基本信息

中文名称:
硝西泮 
中文别名:
硝西泮;
1,3-二氢-7-硝基-5-苯基-2H-1,4-苯并二氮杂酮-2;
硝基安定;
5-苯基-7-硝基-1,3-二氢-2H-1,4-苯并二氮杂卓-2-酮 
英文名称:
Nitrazepam
英文别名:
nitrazepam;
Nitrazepam;
7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one 
CAS No.:
146-22-5
分 子 式:

C15H11N3O3

分 子 量:
281.27
精确分子量:
281.08000
PSA:
87.28000
MDL:
MFCD00058577
EINECS:
205-665-2
InChI:
InChI=1/C18H17ClN2O/c1-11(2)16-18(22)20-15-9-8-13(19)10-14(15)17(21-16)12-6-4-3-5-7-12/h3-11,16H,1-2H3,(H,20,22)
危险品标志:

HarmfulXn

风险术语:

R22

安全术语:

S36/37/39

分子结构式:
SDS:
查看

硝西泮 制备方法及用途

制备方法

2-氨基-5-硝基二苯酮(见02420)溶于干燥的苯,搅拌下滴加氯乙酰氯,升温回流4h,生成2-氯乙酰胺基-5-硝基二苯酮。将基与六次甲基四胺和乙醇加热回流20h,然后蒸馏回收乙醇,过滤得到粗品,再经脱以重结晶,得硝西泮成品。

合成制备方法

2-氨基-5-硝基二苯酮(见02420)溶于干燥的苯,搅拌下滴加氯乙酰氯,升温回流4h,生成2-氯乙酰胺基-5-硝基二苯酮。将基与六次甲基四胺和乙醇加热回流20h,然后蒸馏回收乙醇,过滤得到粗品,再经脱以重结晶,得硝西泮成品。

用途简介

该品为苯二氮类药,具有催眠、松驰肌肉、抗惊厥和抗焦虑作用。服药15-30min入睡,持续6-8h,接近自然睡眠。

用途

该品为苯二氮类药,具有催眠、松驰肌肉、抗惊厥和抗焦虑作用。服药15-30min入睡,持续6-8h,接近自然睡眠。

硝西泮 物化性质

外观与性状:
粉红色固体
密度:
1.4 g/cm3
熔点:
226-229ºC
沸点:
497ºC at 760 mmHg
闪点:
254.4ºC
折射率:
1.627
蒸汽压:
6.33E-09mmHg at 25°C
存储条件/存储方法:

密封于干燥阴凉处保存。

稳定性相关:

常温常压下稳定。

其它信息:

一、物性数据:

1.      性状:淡黄色片状结晶

    2.  溶解性:溶于乙醇、丙酮、氯仿、乙酸乙酯、二氯甲烷,不溶于水、乙醚、苯和已烷

    3.  熔点(ºC):226-229ºC(分解)

硝西泮 安全信息

包装等级:
III
风险类别:
6.1(b)
WGK_Germany:
3
德国有关水污染物质的分类清单
危险类别码:
R22
安全说明:
S36/37/39
RTECS号:
DF2450000
安全标志:
:
危险标志:
Xn:Harmful

硝西泮 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DF2450000
CHEMICAL NAME :
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-
CAS REGISTRY NUMBER :
146-22-5
BEILSTEIN REFERENCE NO. :
0757185
LAST UPDATED :
199612
DATA ITEMS CITED :
24
MOLECULAR FORMULA :
C15-H11-N3-O3
MOLECULAR WEIGHT :
281.29
WISWESSER LINE NOTATION :
T67 GMV JN IHJ CNW KR

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
825 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
733 mg/kg
TOXIC EFFECTS :
Behavioral - anticonvulsant
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
550 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - excitement
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
275 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>400 mg/kg
TOXIC EFFECTS :
Behavioral - excitement
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
130 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
520 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
520 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
4515 mg/kg/30D-I
TOXIC EFFECTS :
Blood - changes in erythrocyte (RBC) count Blood - changes in leukocyte (WBC) count Biochemical - Metabolism (Intermediary) - lipids including transport
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
15750 mg/kg/9W-I
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death Related to Chronic Data - changes in testicular weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
100 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
200 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
300 mg/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
300 mg/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
156 mg/kg
SEX/DURATION :
female 26 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
414 mg/kg
SEX/DURATION :
male 5 day(s) pre-mating female 3 week(s) pre-mating - 3 week(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4) Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1 gm/kg
SEX/DURATION :
male 5 day(s) pre-mating female 15 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - mating performance (e.g. # sperm positive females per # females mated; # copulations per # estrus cycles)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
126 mg/kg
SEX/DURATION :
female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
300 mg/kg/15D (Continuous)
REFERENCE :
CYTBAI Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK) V.1- 1969- Volume(issue)/page/year: 36,45,1983
毒理学数据:

二、毒理学数据:

1、急性毒性:大鼠经口LD50825 mg/kg

大鼠腹腔LD50733 mg/kg

小鼠经口LD50550 gm/kg

小鼠腹腔LD50275 mg/kg

小鼠皮下LD50>400 mg/kg

小鼠静脉LD50130 mg/kg

兔子经口LD50520 mg/kg

生态数据:

三、生态学数据:

其它有害作用:该物质对环境可能有危害,对水体应给予特别注意。

硝西泮 分子结构与计算化学数据

分子结构数据

 

五、分子性质数据:

1、  摩尔折射率:76.64

2、  摩尔体积(m3/mol):200.6

3、  等张比容(90.2K):559.7

4、  表面张力(dyne/cm):60.6

5、  极化率10-24cm3):30.38

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:1

3.氢键受体数量:4

4.可旋转化学键数量:1

5.互变异构体数量:10

6.拓扑分子极性表面积87.3

7.重原子数量:21

8.表面电荷:0

9.复杂度:452

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

推荐供应商更多供应商>>